Amh^tm2Bhr

Point mutations were introduced in the promoter region corresponding to the SF-1 (Nr5a1) binding site. These mutations had been previously shown to abolish binding in an in vitro assay and in transgenic mouse studies. A loxP-flanked neomycin selection cassette was placed within intron 1. (J:58474)